CORC

在结果中检索

CORC

浏览/检索结果: 共29条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Encapsulated Ni-Co alloy nanoparticles as efficient catalyst for hydrodeoxygenation of biomass derivatives in water 期刊论文
CHINESE JOURNAL OF CATALYSIS, 2021, 卷号: 42
作者:  Wang, Dongdong;  Gong, Wanbing;  Zhang, Jifang;  Han, Miaomiao;  Chen, Chun
收藏  |  浏览/下载：61/0  |  提交时间：2021/11/01
In situ growth of MOFs on Ni(OH)(2) for efficient electrocatalytic oxidation of 5-hydroxymethylfurfural 期刊论文
CHEMICAL COMMUNICATIONS, 2021, 卷号: 57
作者:  Wang, Dongdong;  Gong, Wanbing;  Zhang, Jifang;  Wang, Guozhong;  Zhang, Haimin
收藏  |  浏览/下载：11/0  |  提交时间：2021/11/15
A validated HPLC-MS/MS method for determination of simmitecan and its metabolite chimmitecan in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumor 期刊论文
JOURNAL OF SEPARATION SCIENCE, 2021, 页码: 8
作者:  Zhou, Jun;  Zhan, Yan;  Zhong, Dafang;  Chen, Xiaoyan;  Zhang, Yifan
收藏  |  浏览/下载：72/0  |  提交时间：2021/11/04
In Situ Growth of Ultrathin Ni(OH)(2) Nanosheets as Catalyst for Electrocatalytic Oxidation Reactions 期刊论文
CHEMSUSCHEM, 2021
作者:  Zhang, Jifang;  Gong, Wanbing;  Yin, Huajie;  Wang, Dongdong;  Zhang, Yunxia
收藏  |  浏览/下载：21/0  |  提交时间：2021/08/31
Updated safety and efficacy of MSB2311 (an anti-programmed death-ligand 1 antibody) in Chinese patients with advanced solid tumors and hematological malignancies from a phase 1 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Shen, Lin;  Gong, Jifang;  Zhang, Jian;  Ji, Dongmei;  Zhong, Haijun
收藏  |  浏览/下载：21/0  |  提交时间：2022/01/10
Time Course of Attention Interruption After Transient Pain Stimulation 期刊论文
JOURNAL OF PAIN, 2020, 卷号: 21, 期号: 11-12, 页码: 1247-1256
作者:  Gong, Wenxiao;  Li, Jifang;  Luo, Fei
收藏  |  浏览/下载：39/0  |  提交时间：2021/03/01
Challenges in anticancer drug R&D in China 期刊论文
LANCET ONCOLOGY, 2019, 卷号: 20, 期号: 2
作者:  Zhao, Shen;  Lv, Cheng;  Gong, Jifang;  Fang Wenfeng;  Hu, Xichun
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 期刊论文
HEPATOLOGY, 2018, 卷号: 68
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace